Neuroendocrine-immune system in patients with rheumatoid arthritis

Modern Rheumatology

Volumn 13, Issue 3, 2003, Pages 193-198

  Yoshino, Shinichi ^a   Mukai, Eiichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Brain reset mechanism; Emotional status; Heart laughter; Neuroendocrine immune system; Rheumatoid arthritis (RA)

Indexed keywords

ADRENALIN; ANESTHETIC AGENT; BETA ENDORPHIN; CD4 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; HYDROCORTISONE; INTERLEUKIN 6; METENKEPHALIN; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADULT; BLOOD ANALYSIS; BLOOD LEVEL; CELL ACTIVITY; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CRYING; DOPAMINE BLOOD LEVEL; DRUG RESPONSE; EMOTION; FEMALE; GENERAL ANESTHESIA; HOMEOSTASIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHESIS; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MENTAL STRESS; NATURAL KILLER CELL; NEUROENDOCRINE SYSTEM; NEUROMODULATION; NONVERBAL COMMUNICATION; NORADRENALIN BLOOD LEVEL; OSTEOARTHRITIS; PERIPHERAL CIRCULATION; PHYSICAL STRESS; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0141927262     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-003-0223-z     Document Type: Review

References (68)

1. Cousins N. Anatomy of an illness (as perceived by the patient). N Engl J Med 1976;295:1458-63.
2. Dugué B, Leppänen EA, Teppo AM, Fyhrquist F, Grasbeck R. Effects of psychological stress on plasma interleukin-1-beta and -6, C-reactive protein, tumor necrosis factor alpha, anti-diuretic hormone and serum cortisol. Scand J Clin Lab Invest 1993;53:555-61.
3. Harrington L, Affleck G, Urrows S, Urrows S, Tennen H, Higgins P, et al. Temporal covariation of soluble interleukin-2 receptor levels, daily stress, and disease activity in rheumatoid arthritis. Arthritis Rheum 1993;36:199-203.
4. Cutolo M, Prete C, Walker J. Is stress a factor in the pathogenesis of autoimmune rheumatic disease? Clin Exp Rheumatol 1999; 17:515-8.
5. Selye H. The evolution of stress concept. Am Sci 1973;61:692-9.
6. Taylor R. Regulation of the immune response. 2nd ed, London: Gower; 1989. p. 10.1.
7. Neeck G, Federlin K, Graef V, Schmidt KL. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J Rheumatol 1990;17: 24-9.
8. Hill SR Jr, Holley HL, Ulloa A, Starnes WR, Hibbitt LL, McNeil JH. Studies on adrenal cortical activity in patients with rheumatoid aethritis: the diural pattern and twenty-four levels of urinary total 17-hydroxycorticosteroids and 17-ketosteroids. Arthritis Rheum 1959;2:114-26.
9. Hill SR Jr, Ulloa A, Starnes WR, Holley HL. Corticosteroids in rheumatoid arthritis: studies on aldosterone,17-hydroxycortico-steroid, and 17-ketosteroid response to corticotropin in male patients with rheumatoid arthritis. Arch Intern Med 1963;112:603-11.
10. Masi AT, Josipovic DB, Jeffeson WE. Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11?deoxy-17-ketosteroid excretion. Semin Arthritis Rheum 1984;14:1-23.
11. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992; 35:1281-8.
12. Jorgensen C, Bressot N, Bologna C, Sany J. Dysregulation of the hypothalo-pituitary axis in rheumatoid arthritis. J Rheumatol 1955;22:1829-33.
13. Kirkham BW, Corkill NM, Davision SC, Panayi GS. Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell-mediated immune assay predicts in vivo responses. J Rheumatol 1991;18:821-5.
14. Schlaghecke R, Kornley E, Wollenhaupt J, Specker C. Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum 1992;35: 740-4.
15. Cashu JM, Crofford LJ, Galluccl WT, Sternberg EM, Gold PW, Chrousos GP, et al. Pituitary-adrenal axis responsiveness to ovine corticotropin-releasing hormone in patients with rheumatoid arthritis treated with low-dose prednisone. J Rheumatol 1992;19: 1692-6.
16. Imrich R. The role of neuroendocrine system in the pathogenesis of rheumatic disease (minireview). Endocr Regul 2002;36(2):95-106.
17. Wilder RL. Neuroimmunoendocrinology of rheumatic disease: past, present, and future. Ann NY Acad Sci 2002;966:13-9.
18. Straub RH, Cutalo M. Involvement of the hypothalamic-pituitary-adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum 2001;44:493-507.
19. Chikanza IC. The neuroendocrine immunology of rheumatoid arthritis. Baillieres Clin Rheumatol 1996;10:273-93.
20. Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 1995;13:307-38.
21. Panayi GS. The pathogenesis of rheumatoid arthritis: from molecules to the whole patient. Br J Rheumatol 1993;32:533-6.
22. Mukai E, Nagashima M, Hirano D, Yoshino S. Comparative study of symptoms and neuroendocrine-immune network mediator levels between rheumatoid arthritis patients and healthy subjects. Clin Exp Rheumtol 2000;18;585-90.
23. Panerai AE, Sacerdote P. β-endorphin in the imune system: a role at last? Immunol Today 1997;18:317-9.
24. Kuroda Y, Mori T, Hori T. Resistraint stress suppresses experimental allergic encephalomyelitis in Lewis rats. Brain Res Bull 1994;34:15-7.
25. Blanc JP, Taylor JW, Miller RJ, Kaiser ET. Examination of the requirement for an amphiphilic helical structure in beta-endorphin through the design, synthesis, and study of model peptides. J Biol Chem 1983;258:8277-84.
26. Denco CW, Aponte J, Gabriel P, Petricevic M. Serum β-endorphin in rheumatic disorders. J Rheumatol 1982;9:827-33.
27. Suzuki N, Yoshino S, Nakamura H. A study of opioid peptides in synovial fluid and synovial tissue in patients with rheumatoid arthritis. Allergy 1992;41:615-20.
28. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1955;332:1351-62.
29. Hall J, Moramd EF, Medbak S, Zaman M, Perry L, Goulding NJ, et al. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis: effects of nonsteroidal anti-inflammatory drugs and water immersion. Arthritis Rheum 1994;37:1132-7.
30. Nakamura H, Yoshino S, Kouda M. A study of neuropeptide and cytokines in sera from patients with rheumatoid arthritis. Allergy 1993;42:1806-11.
31. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 1993:262:1011-8.
32. Gratama JW, Fibbe WE, Naipal AM, Slats J, Stijnen T, D'Amaro J, et al. Cytomegalovirus immunity and T lymphocytes in bone marrow donors and acute graft-versus host disease. Bone Marrow Transplant 1986;1:141-6.
33. Zander AR, Reuben JM, Johnston D, Vellekoop L, Dicke KA, Yau JC, et al. Immune recovery following allogenic bone marrow transplantation. Transplantation 1985;40:177-83.
34. Menitove JE, Aster RH, Caper JT, Lauser SJ, Gottschall JL, Wiliams JE, et al. T lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. New Engl J Med 1983;308:83-6.
35. Fonseca JE, Edwards JC, Blades S, Goulding NJ. Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments. Arthritis Rheum 2002;46:1210-6.
36. Chakravarti A. The CD4/CD8 ratio: message in a bottle? Nature Med 1995;1:1240-1.
37. Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GN, et al. Genetic control of the CD4/CD8 ratio in humans. Nature Med 1995;1:1279-83.
38. Hendrich C, Kuipers JG, Kolanus W, Hammer M, Schmidt RE. Activation of CD16+ effector cells by rheumatoid factor complex: role of natural killer cells in rheumatoid arthritis. Arthritis Rheum 1991;34:423-31.
39. Irwin M, Patterson T, Smith TL, Caldwell C, Brown SA, Gillin JC, et al. Reduction of immune function in life stress and depression. Biol Psychiatry 1990;27:22-30.
40. Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987;139:3306-13.
41. Klimas NG, Salvato FR, Morgan RE, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990;28:1403-10.
42. Schedlowski BK, Jacobs R, Stratmann G, Richter S, Hadicke A, Tews U, et al. Changes of natural killer cells during acute psychological stress. J Clin Immunol 1993;13:119-26.
43. Irwin M, Brown M, Patterson T, Hauger A, Mascovich A, Grant I. Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer care-giver stress. Neural modulation of immunity. 1991;5:3100-7.
44. Lin GL, Arthur J, Vander JK. The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol Behav 1990;47:957-61.
45. Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabins BS. Exposure to physical and psychological stressors elevates plasma interleukin-6: relationship to the activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 1993;133:2523-30.
46. Takaki A, Huang QH, Somogyvari-Vigh A, Arima A. Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation 1994;1:335-42.
47. Hall J, Morand EF, Medbak S, Zaman M, Perry L, Goulding NJ. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Arthritis Rheum 1994;37:1132-7.
48. Zhou D, Shanks N, Riechman SE, Liang R, Kusnecov AW, Rabins BS. Interleukinn-6 modulates interleukin-1 and stress-induced activation of the hypothalamic-pituitary-adrenal axis in male rats. Neuroendocrinology 1996;63:227-36.
49. Shizuya K, Komori T, Fujiwara R, Miyahara S, Ohmori M, Nomura J. The influence of restraint stress on the expression of mRNAs for IL-6 receptor in the hypothalamus and midbrain of the rat. Life Sci 1997;61:135-40.
50. Shizuya K, Komori T, Fujiwara R, Miyahara S, Ohmori M, Nomura J. The expression of mRNAs for interleukin-6 (IL-6) and the IL-6 receptor (IL-6R) in the rat hypothalamus and midbrain during restraint stress. Life Sci 1998;62:2315-20.
51. Baker GHB. Life events before the onset of rheumatoid arthritis. Psychother Psychosom 1982;38:173-7.
52. Selye H. A syndrome produced by diverse noxious agents. Nature 1936;138:32.
53. Fujiwara R, Yokohama M. The interrelationship of stress and immune response. Igakunoayumi 1994;154:355-8.
54. Teshima H, Sagawa H, Kihara H, Nagata S, Ago Y, Nakagawa T. Change in population of T cell subsets due to stress. Ann NY Acad Sci 1987;496:459-66.
55. Bartop RW, Luckhurst E, Lazarus L, Kiloh LG. Depressed lymphocyte function after bereavement. Lancet 1977;16:834-6.
56. Potitto JM, Folds JD, Ozer H, Quade D, Evans DL. Abnormal diurnal variation in circulating natural killer cell phenotypes and cytotoxic activity in major depression. Am J Psychiatry 1992;149: 694-6.
57. Zisook S, Shuchter SR, Irwin M, Darko DF, Sledge P, Resovsky K. Bereavement, depression, and immune function. Psychiatry Res 1994;52:1-10.
58. Knapp PH, Levy EM, Giorgi RG, Black PH, Fox BH, Heeren TC. Short-term immunological effects of induced emotion. Psychosom Med 1992;54:133-48.
59. Dillon KM, Minchoff B, Baker KH. Positive emotional status and enhancement of the immune system. Int J Psychiatry Med 1985; 15:13-8.
60. Dillon KM, Totten MC. Psychological factor immunocompetence, and their infants. J Genet Psychol 1989;150:155-62.
61. Fry MF Jr. The physiologic effects of humor, mirth, and laughter. JAMA 1992;267:1857-8.
62. Cousins N. Anatomy of an illness (as perceived by the patient). N Engl J Med 1976;295:1458-63.
63. Yoshino S, Fujimori J, Kohda M. Effects of mirthful laughter on neuroendocrine and immune system in patients with rheumatoid arthritis. J Rheumatol 1996;23:793-4.
64. Nakajima A, Hirai H, Yoshino S. Reassessment of mirthful laughter in rheumatoid arthritis. J Rheumatol 1999;26:512-3.
65. Firestein GS, Zvaifler NJ. Anticytokine therapy in rheumatoid arthritis. N Engl J Med 1997;337:195-7.
66. Ishii H, Iwakawa G, Nagashima M, Yoshino S. Psychological stress induced by deep emotion with tears effects on neuroendocrine and immune response in patients with rheumatoid arthritis. Arthritis Rheum 2001;44(S250 supplement):1354.
67. Ishii H, Iwakawa K, Tannno M, Nakajima A, Yoshino S. The relationship between emotional sensitivity and the control and prognosis of rheumatoid arthritis. Arthritis Rheum 2002;46(S330 supplement):833.
68. Hirano D, Nagashima M, Ogawa R, Yoshino S. Serum levels of interleukin-6 and stress-related substances indicate mental stress condition in patients with rheumatoid arthritis. J Rheumatol 2001;28:490-5.